Pharmaceutical

‘I don’t see this as an end to the pandemic’: Ashish Jh...

As the coronavirus public health emergency expires, White House Covid-19 Respons...

STAT+: Lawmakers press CMS to release new breakthrough ...

Lawmakers echoed device makers' call for an easier pathway to CMS reimbursement ...

STAT+: Insulin makers, PBMs echo old finger-pointing in...

A Senate hearing on high insulin costs billed as a blockbuster showdown with dru...

STAT+: Skin patch for toddlers with peanut allergy show...

If the FDA eventually approves the skin patch, it would become the first treatme...

Black patients far less likely to receive key opioid ad...

Few people with opioid addiction can access the highly effective drugs used to t...

Ask STAT: What do you want to know about ChatGPT in med...

What do you want to know about ChatGPT and generative AI in science and medicine...

FDA panel votes in favor of the first over-the-counter ...

In a highly significant move, a panel of independent experts voted unanimously t...

Synlogic’s SYNB1934 receives orphan drug status from US...

SYNB1934 has also received orphan drug designation from the European Medicines A...

China clears sNDA for combination therapy of NSCLC

Approval was given to TYVYT (sintilimab injection) plus bevacizumab and chemothe...

Amgen enlists TScan’s target discovery platform for Cro...

TScan will receive $30m upfront and a possible $500m in milestones to aid T cell...

Gilead wins patent battle with US government over HIV P...

A federal jury has ruled in favour of Gilead, stating that the government’s pate...

First-in-class migraine treatment Vydura approved for N...

The Scottish Medicines Consortium includes the first gepant for migraines on NHS...

Sobi agrees to buy CTI BioPharma for $1.7bn

The acquisition will strengthen Sobi's haematology medicines portfolio with the ...

Alvotech and Polifarma sign agreement to commercialise ...

The trial will assess the efficacy, safety and immunogenicity of the therapy com...

CytoMed and MD Anderson partner to use gdTc for cancer ...

The research teams will examine the use of CytoMed’s allogeneic gdTc on multiple...

Roche buys worldwide rights to Zion Pharma’s ZN-A-1041

ZN-A-1041 targets the human epidermal growth factor receptor 2 and is designed t...